# pathway_0188: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0188.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Alkaloid biosynthesis

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MEIMNFSLNSPVFLLLSFFFLLMVLMQLTGSRKYKGKRLPPGPKKLPIIGNLHQMVGSLPHRVLKNLADQYGPVMHLQIGELSAIVISSADKAKEVLNTHGILVADRPQTTVAKIMLYNSLGATFAPYGDYLKQLRQIYALELLSPKTVRSFWTIMEDELSTMVTSVKAEAGQPIVLHDRMLTYLYATLCRATVGSVCNGRETLIMAAKETSALSAAIRIEDLFPSVKILPVVSGLRTRLTNLLKQLDTVLEDIIGEREKKMFSSNNIQPSTEEEDMLGVLLLYKNGKGKDTKFRITNNDIKAIIFELILAGTLSSSAIVEWCMSEMIKNPRVMKKAQDEVRQVLKDKKKVSGSDLAKLEYVKMVIKESVRLHPPAPLLFPREVREDFEMDGMIIPKKSWVIINYWAVGIDPKIWDDAERFEPERFSNSPIDFYGSHFELIPFGAGRRICPGILFGTTNVELLLASFLYHFDWKLPGGMKPEELDMNELFGAGCIRENPLCLIPSISVAGN

[Multiple Choices]
A. Protein modification
B. Alkaloid biosynthesis
C. dTTP biosynthesis. .
D. 7,8-dihydrofolate from 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate and 4-aminobenzoate: step 1/2. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact supplied sequence matches the UniProt entry annotated with the pathway “Alkaloid biosynthesis; ajmaline biosynthesis.” The annotation carries ECO:0000269 and cites a study whose stated subject is ajmaline biosynthesis, supporting choice B for this protein.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is compatible with a membrane-associated cytochrome P450, but that broad protein class does not establish a specific metabolic pathway or distinguish alkaloid biosynthesis from other possible P450 roles.


**Missing item-specific fact**

> The protein-specific link between this sequence (Sarpagan bridge enzyme 2) and ajmaline/alkaloid biosynthesis.


**Reason**

> Identifying the pathway requires an item-specific functional annotation or experimental finding not supplied in the question. Recognizing general P450 sequence features does not resolve the pathway choice.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer-only sequence-matched annotation supports B; the choices do not provide another comparably supported pathway for this protein.


### Important caveats

- The pathway annotation is database evidence, not information available to the evaluated model.
- The cited primary study was not independently reviewed here; the historical UniProt record attributes the pathway annotation to it.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is compatible with a membrane-associated cytochrome P450, but that broad protein class does not establish a specific metabolic pathway or distinguish alkaloid biosynthesis from other possible P450 roles.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific link between this sequence (Sarpagan bridge enzyme 2) and ajmaline/alkaloid biosynthesis.",
    "reason": "Identifying the pathway requires an item-specific functional annotation or experimental finding not supplied in the question. Recognizing general P450 sequence features does not resolve the pathway choice."
  },
  "case_id": "pathway_0188",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the UniProt entry annotated with the pathway “Alkaloid biosynthesis; ajmaline biosynthesis.” The annotation carries ECO:0000269 and cites a study whose stated subject is ajmaline biosynthesis, supporting choice B for this protein."
  },
  "important_caveats": [
    "The pathway annotation is database evidence, not information available to the evaluated model.",
    "The cited primary study was not independently reviewed here; the historical UniProt record attributes the pathway annotation to it."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer-only sequence-matched annotation supports B; the choices do not provide another comparably supported pathway for this protein."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0188",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact supplied sequence matches the UniProt entry annotated with the pathway “Alkaloid biosynthesis; ajmaline biosynthesis.” The annotation carries ECO:0000269 and cites a study whose stated subject is ajmaline biosynthesis, supporting choice B for this protein.",
    "evidence_ids": ["C5", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is compatible with a membrane-associated cytochrome P450, but that broad protein class does not establish a specific metabolic pathway or distinguish alkaloid biosynthesis from other possible P450 roles.",
    "missing_item_specific_fact": "The protein-specific link between this sequence (Sarpagan bridge enzyme 2) and ajmaline/alkaloid biosynthesis.",
    "reason": "Identifying the pathway requires an item-specific functional annotation or experimental finding not supplied in the question. Recognizing general P450 sequence features does not resolve the pathway choice."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer-only sequence-matched annotation supports B; the choices do not provide another comparably supported pathway for this protein."
  },
  "important_caveats": [
    "The pathway annotation is database evidence, not information available to the evaluated model.",
    "The cited primary study was not independently reviewed here; the historical UniProt record attributes the pathway annotation to it."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P0DXJ2 (Sarpagan bridge enzyme 2, RsSBE2) from Rauvolfia serpentina is explicitly annotated with PATHWAY: 'Alkaloid biosynthesis; ajmaline biosynthesis' (ECO:0000269, experimental evidence from PubMed:38212296, Guo et al. Nat. Commun. 2024). Ajmaline is a terpenoid indole alkaloid, so the broader pathway category 'Alkaloid biosynthesis' is correct. The EC number 1.14.14.- (cytochrome P450 monooxygenase) is consistent with a P450 catalyzing a biosynthetic step in alkaloid production.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The C-terminal region contains the canonical cytochrome P450 heme-binding motif (FGAGRRICPGILFGTTNVELLLASFLYHFDWKLPGGMKPEELDMNELFGAGCIRENPLCLIPSISVAGN), with the critical FxxGxxxCxG signature. Cytochrome P450s are NOT the catalytic enzymes in protein modification (kinases/phosphatases), dTTP biosynthesis (thymidylate synthase, nucleotide kinases), or dihydrofolate synthesis (dihydropteroate synthase, folylpolyglutamate synthase). In contrast, P450s are the primary oxidoreductases in plant secondary-metabolite and alkaloid biosynthetic pathways. Thus, identifying the P450 signature from the sequence allows elimination of options A, C, and D, leaving B as the only pathway in which a P450 serves as the principal catalytic enzyme.


**Missing item-specific fact**

> None strictly required; the reasoning path from P450 identification to pathway elimination uses general enzymology and plant biochemistry knowledge rather than a protein-specific database lookup.


**Reason**

> A knowledgeable model can recognize the P450 heme-binding domain in the sequence and apply general knowledge that P450s catalyze oxidations in alkaloid/secondary-metabolite biosynthesis but are not the operative enzymes in protein modification, nucleotide biosynthesis, or folate synthesis. This provides a concrete, sequence-grounded biological argument that distinguishes option B from the distractors without memorizing this particular entry's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options represent mechanistically distinct pathway types. A cytochrome P450 is not a plausible catalytic enzyme for protein modification, dTTP biosynthesis, or dihydrofolate synthesis. Only alkaloid biosynthesis is a pathway where P450s are the principal catalytic enzymes, so the sequence-derived P450 identification cleanly selects option B.


### Important caveats

- The UniProt annotation carries ECO:0000269 (experimental evidence) from a 2024 Nature Communications paper, lending strong support to the pathway assignment.
- The EC number is assigned by similarity (ECO:0000250, transferred from P0DO13), not experimentally determined for this specific enzyme, though the pathway comment itself is experimentally supported.
- The reasoning path relies on recognizing the P450 motif and knowing general catalytic roles; a model that fails to identify the P450 signature would lack the basis for elimination.
- The specific alkaloid (ajmaline) and the exact enzymatic step (sarpagan bridge formation) are not inferable from the sequence alone, but the broader pathway category 'Alkaloid biosynthesis' is reachable via P450-based reasoning.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The C-terminal region contains the canonical cytochrome P450 heme-binding motif (FGAGRRICPGILFGTTNVELLLASFLYHFDWKLPGGMKPEELDMNELFGAGCIRENPLCLIPSISVAGN), with the critical FxxGxxxCxG signature. Cytochrome P450s are NOT the catalytic enzymes in protein modification (kinases/phosphatases), dTTP biosynthesis (thymidylate synthase, nucleotide kinases), or dihydrofolate synthesis (dihydropteroate synthase, folylpolyglutamate synthase). In contrast, P450s are the primary oxidoreductases in plant secondary-metabolite and alkaloid biosynthetic pathways. Thus, identifying the P450 signature from the sequence allows elimination of options A, C, and D, leaving B as the only pathway in which a P450 serves as the principal catalytic enzyme.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None strictly required; the reasoning path from P450 identification to pathway elimination uses general enzymology and plant biochemistry knowledge rather than a protein-specific database lookup.",
    "reason": "A knowledgeable model can recognize the P450 heme-binding domain in the sequence and apply general knowledge that P450s catalyze oxidations in alkaloid/secondary-metabolite biosynthesis but are not the operative enzymes in protein modification, nucleotide biosynthesis, or folate synthesis. This provides a concrete, sequence-grounded biological argument that distinguishes option B from the distractors without memorizing this particular entry's annotation."
  },
  "case_id": "pathway_0188",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P0DXJ2 (Sarpagan bridge enzyme 2, RsSBE2) from Rauvolfia serpentina is explicitly annotated with PATHWAY: 'Alkaloid biosynthesis; ajmaline biosynthesis' (ECO:0000269, experimental evidence from PubMed:38212296, Guo et al. Nat. Commun. 2024). Ajmaline is a terpenoid indole alkaloid, so the broader pathway category 'Alkaloid biosynthesis' is correct. The EC number 1.14.14.- (cytochrome P450 monooxygenase) is consistent with a P450 catalyzing a biosynthetic step in alkaloid production."
  },
  "important_caveats": [
    "The UniProt annotation carries ECO:0000269 (experimental evidence) from a 2024 Nature Communications paper, lending strong support to the pathway assignment.",
    "The EC number is assigned by similarity (ECO:0000250, transferred from P0DO13), not experimentally determined for this specific enzyme, though the pathway comment itself is experimentally supported.",
    "The reasoning path relies on recognizing the P450 motif and knowing general catalytic roles; a model that fails to identify the P450 signature would lack the basis for elimination.",
    "The specific alkaloid (ajmaline) and the exact enzymatic step (sarpagan bridge formation) are not inferable from the sequence alone, but the broader pathway category 'Alkaloid biosynthesis' is reachable via P450-based reasoning."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent mechanistically distinct pathway types. A cytochrome P450 is not a plausible catalytic enzyme for protein modification, dTTP biosynthesis, or dihydrofolate synthesis. Only alkaloid biosynthesis is a pathway where P450s are the principal catalytic enzymes, so the sequence-derived P450 identification cleanly selects option B."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0188",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry P0DXJ2 (Sarpagan bridge enzyme 2, RsSBE2) from Rauvolfia serpentina is explicitly annotated with PATHWAY: 'Alkaloid biosynthesis; ajmaline biosynthesis' (ECO:0000269, experimental evidence from PubMed:38212296, Guo et al. Nat. Commun. 2024). Ajmaline is a terpenoid indole alkaloid, so the broader pathway category 'Alkaloid biosynthesis' is correct. The EC number 1.14.14.- (cytochrome P450 monooxygenase) is consistent with a P450 catalyzing a biosynthetic step in alkaloid production.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The C-terminal region contains the canonical cytochrome P450 heme-binding motif (FGAGRRICPGILFGTTNVELLLASFLYHFDWKLPGGMKPEELDMNELFGAGCIRENPLCLIPSISVAGN), with the critical FxxGxxxCxG signature. Cytochrome P450s are NOT the catalytic enzymes in protein modification (kinases/phosphatases), dTTP biosynthesis (thymidylate synthase, nucleotide kinases), or dihydrofolate synthesis (dihydropteroate synthase, folylpolyglutamate synthase). In contrast, P450s are the primary oxidoreductases in plant secondary-metabolite and alkaloid biosynthetic pathways. Thus, identifying the P450 signature from the sequence allows elimination of options A, C, and D, leaving B as the only pathway in which a P450 serves as the principal catalytic enzyme.",
    "missing_item_specific_fact": "None strictly required; the reasoning path from P450 identification to pathway elimination uses general enzymology and plant biochemistry knowledge rather than a protein-specific database lookup.",
    "reason": "A knowledgeable model can recognize the P450 heme-binding domain in the sequence and apply general knowledge that P450s catalyze oxidations in alkaloid/secondary-metabolite biosynthesis but are not the operative enzymes in protein modification, nucleotide biosynthesis, or folate synthesis. This provides a concrete, sequence-grounded biological argument that distinguishes option B from the distractors without memorizing this particular entry's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent mechanistically distinct pathway types. A cytochrome P450 is not a plausible catalytic enzyme for protein modification, dTTP biosynthesis, or dihydrofolate synthesis. Only alkaloid biosynthesis is a pathway where P450s are the principal catalytic enzymes, so the sequence-derived P450 identification cleanly selects option B."
  },
  "important_caveats": [
    "The UniProt annotation carries ECO:0000269 (experimental evidence) from a 2024 Nature Communications paper, lending strong support to the pathway assignment.",
    "The EC number is assigned by similarity (ECO:0000250, transferred from P0DO13), not experimentally determined for this specific enzyme, though the pathway comment itself is experimentally supported.",
    "The reasoning path relies on recognizing the P450 motif and knowing general catalytic roles; a model that fails to identify the P450 signature would lack the basis for elimination.",
    "The specific alkaloid (ajmaline) and the exact enzymatic step (sarpagan bridge formation) are not inferable from the sequence alone, but the broader pathway category 'Alkaloid biosynthesis' is reachable via P450-based reasoning."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record annotates the protein in alkaloid biosynthesis, specifically ajmaline biosynthesis, with ECO:0000269 evidence linked to a publication. This supports choice B, though it is database-reported evidence rather than an independent review of the underlying experiments.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence has a hydrophobic N-terminal segment and a conserved C-terminal cysteine-containing region characteristic of a membrane-associated cytochrome P450. P450 enzymes commonly catalyze oxidative steps in plant specialized metabolism, including alkaloid biosynthesis. Among these options, that provides a meaningful basis for B over the specific nucleotide and folate biosynthesis choices, while the sequence alone does not establish the exact alkaloid pathway.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A transferable P450-family inference meaningfully favors alkaloid biosynthesis among the offered alternatives. It is probabilistic: P450s have diverse functions, and the sequence motifs alone do not identify the particular product or pathway.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The alternatives are distinct enough that the P450-based inference favors B; no other listed option is comparably supported by the sequence features.


### Important caveats

- The supplied sequence supports recognition of a P450-like enzyme but does not by itself prove its specific pathway assignment.
- The reviewer-only annotation applies to the sequence-matched record and reports experimental evidence, but the underlying study was not independently assessed here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has a hydrophobic N-terminal segment and a conserved C-terminal cysteine-containing region characteristic of a membrane-associated cytochrome P450. P450 enzymes commonly catalyze oxidative steps in plant specialized metabolism, including alkaloid biosynthesis. Among these options, that provides a meaningful basis for B over the specific nucleotide and folate biosynthesis choices, while the sequence alone does not establish the exact alkaloid pathway.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A transferable P450-family inference meaningfully favors alkaloid biosynthesis among the offered alternatives. It is probabilistic: P450s have diverse functions, and the sequence motifs alone do not identify the particular product or pathway."
  },
  "case_id": "pathway_0188",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates the protein in alkaloid biosynthesis, specifically ajmaline biosynthesis, with ECO:0000269 evidence linked to a publication. This supports choice B, though it is database-reported evidence rather than an independent review of the underlying experiments."
  },
  "important_caveats": [
    "The supplied sequence supports recognition of a P450-like enzyme but does not by itself prove its specific pathway assignment.",
    "The reviewer-only annotation applies to the sequence-matched record and reports experimental evidence, but the underlying study was not independently assessed here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The alternatives are distinct enough that the P450-based inference favors B; no other listed option is comparably supported by the sequence features."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0188",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates the protein in alkaloid biosynthesis, specifically ajmaline biosynthesis, with ECO:0000269 evidence linked to a publication. This supports choice B, though it is database-reported evidence rather than an independent review of the underlying experiments.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence has a hydrophobic N-terminal segment and a conserved C-terminal cysteine-containing region characteristic of a membrane-associated cytochrome P450. P450 enzymes commonly catalyze oxidative steps in plant specialized metabolism, including alkaloid biosynthesis. Among these options, that provides a meaningful basis for B over the specific nucleotide and folate biosynthesis choices, while the sequence alone does not establish the exact alkaloid pathway.",
    "missing_item_specific_fact": "",
    "reason": "A transferable P450-family inference meaningfully favors alkaloid biosynthesis among the offered alternatives. It is probabilistic: P450s have diverse functions, and the sequence motifs alone do not identify the particular product or pathway."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The alternatives are distinct enough that the P450-based inference favors B; no other listed option is comparably supported by the sequence features."
  },
  "important_caveats": [
    "The supplied sequence supports recognition of a P450-like enzyme but does not by itself prove its specific pathway assignment.",
    "The reviewer-only annotation applies to the sequence-matched record and reports experimental evidence, but the underlying study was not independently assessed here."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXJ2 (Sarpagan bridge enzyme 2, RsSBE2) from Rauvolfia serpentina is annotated with PATHWAY: 'Alkaloid biosynthesis; ajmaline biosynthesis' supported by experimental evidence (ECO:0000269, PubMed:38212296, a 2024 Nature Communications paper on de novo biosynthesis of the antiarrhythmic alkaloid ajmaline). The sequence matches exactly. Answer B 'Alkaloid biosynthesis' is directly supported.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a recognizable cytochrome P450 heme-binding motif (FGAGRRICPGILFGTTNVELLL near the C-terminus, matching the canonical FGxxxCxG pattern with the conserved cysteine that ligates heme iron). The ~511 aa length, hydrophobic N-terminal membrane anchor, and overall architecture are consistent with a plant microsomal P450. Recognizing the protein as a P450 eliminates options C (dTTP biosynthesis: uses ribonucleotide reductase, thymidylate synthase, dUTPase — none are P450s) and D (dihydrofolate biosynthesis: uses GTP cyclohydrolase, dihydropteroate synthase, folylpolyglutamate synthase — none are P450s). Option A (Protein modification) is atypical for P450s, which oxidize small-molecule substrates rather than modifying proteins. Plant P450s are overwhelmingly associated with secondary metabolism, particularly alkaloid biosynthesis (e.g., terpenoid indole alkaloids in Apocynaceae/Rubiaceae, morphine biosynthesis in Papaver, etc.), making B the most probable pathway among the remaining choices. This is a well-established family-level pattern learned from many other plant P450s.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can identify the P450 signature from sequence, eliminate non-P450 pathways (C, D), reject protein modification (A) as inconsistent with P450 chemistry, and use the strong empirical association between plant P450s and alkaloid/secondary metabolism to select B. This relies on transferable family knowledge and sequence motif recognition, not on recalling this specific entry's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options represent fundamentally different enzyme classes and metabolic contexts. P450 recognition cleanly eliminates C and D; the chemistry of P450s eliminates A. Only B remains as a plausible pathway for a plant P450. Minor trailing-period formatting in C and D does not affect interpretation.


### Important caveats

- The P450 heme-binding motif is identifiable but requires careful inspection; a model unfamiliar with the FGxxxCxG pattern might struggle, though the overall sequence architecture still suggests a P450.
- The specific sub-pathway (ajmaline biosynthesis) is not asked; the broader category 'Alkaloid biosynthesis' is the correct answer level.
- The entry was first published in June 2025 and the supporting paper appeared in 2024; the benchmark author's source snapshot is unknown but the sequence matches exactly.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a recognizable cytochrome P450 heme-binding motif (FGAGRRICPGILFGTTNVELLL near the C-terminus, matching the canonical FGxxxCxG pattern with the conserved cysteine that ligates heme iron). The ~511 aa length, hydrophobic N-terminal membrane anchor, and overall architecture are consistent with a plant microsomal P450. Recognizing the protein as a P450 eliminates options C (dTTP biosynthesis: uses ribonucleotide reductase, thymidylate synthase, dUTPase — none are P450s) and D (dihydrofolate biosynthesis: uses GTP cyclohydrolase, dihydropteroate synthase, folylpolyglutamate synthase — none are P450s). Option A (Protein modification) is atypical for P450s, which oxidize small-molecule substrates rather than modifying proteins. Plant P450s are overwhelmingly associated with secondary metabolism, particularly alkaloid biosynthesis (e.g., terpenoid indole alkaloids in Apocynaceae/Rubiaceae, morphine biosynthesis in Papaver, etc.), making B the most probable pathway among the remaining choices. This is a well-established family-level pattern learned from many other plant P450s.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can identify the P450 signature from sequence, eliminate non-P450 pathways (C, D), reject protein modification (A) as inconsistent with P450 chemistry, and use the strong empirical association between plant P450s and alkaloid/secondary metabolism to select B. This relies on transferable family knowledge and sequence motif recognition, not on recalling this specific entry's annotation."
  },
  "case_id": "pathway_0188",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXJ2 (Sarpagan bridge enzyme 2, RsSBE2) from Rauvolfia serpentina is annotated with PATHWAY: 'Alkaloid biosynthesis; ajmaline biosynthesis' supported by experimental evidence (ECO:0000269, PubMed:38212296, a 2024 Nature Communications paper on de novo biosynthesis of the antiarrhythmic alkaloid ajmaline). The sequence matches exactly. Answer B 'Alkaloid biosynthesis' is directly supported."
  },
  "important_caveats": [
    "The P450 heme-binding motif is identifiable but requires careful inspection; a model unfamiliar with the FGxxxCxG pattern might struggle, though the overall sequence architecture still suggests a P450.",
    "The specific sub-pathway (ajmaline biosynthesis) is not asked; the broader category 'Alkaloid biosynthesis' is the correct answer level.",
    "The entry was first published in June 2025 and the supporting paper appeared in 2024; the benchmark author's source snapshot is unknown but the sequence matches exactly."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent fundamentally different enzyme classes and metabolic contexts. P450 recognition cleanly eliminates C and D; the chemistry of P450s eliminates A. Only B remains as a plausible pathway for a plant P450. Minor trailing-period formatting in C and D does not affect interpretation."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0188",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXJ2 (Sarpagan bridge enzyme 2, RsSBE2) from Rauvolfia serpentina is annotated with PATHWAY: 'Alkaloid biosynthesis; ajmaline biosynthesis' supported by experimental evidence (ECO:0000269, PubMed:38212296, a 2024 Nature Communications paper on de novo biosynthesis of the antiarrhythmic alkaloid ajmaline). The sequence matches exactly. Answer B 'Alkaloid biosynthesis' is directly supported.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a recognizable cytochrome P450 heme-binding motif (FGAGRRICPGILFGTTNVELLL near the C-terminus, matching the canonical FGxxxCxG pattern with the conserved cysteine that ligates heme iron). The ~511 aa length, hydrophobic N-terminal membrane anchor, and overall architecture are consistent with a plant microsomal P450. Recognizing the protein as a P450 eliminates options C (dTTP biosynthesis: uses ribonucleotide reductase, thymidylate synthase, dUTPase — none are P450s) and D (dihydrofolate biosynthesis: uses GTP cyclohydrolase, dihydropteroate synthase, folylpolyglutamate synthase — none are P450s). Option A (Protein modification) is atypical for P450s, which oxidize small-molecule substrates rather than modifying proteins. Plant P450s are overwhelmingly associated with secondary metabolism, particularly alkaloid biosynthesis (e.g., terpenoid indole alkaloids in Apocynaceae/Rubiaceae, morphine biosynthesis in Papaver, etc.), making B the most probable pathway among the remaining choices. This is a well-established family-level pattern learned from many other plant P450s.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can identify the P450 signature from sequence, eliminate non-P450 pathways (C, D), reject protein modification (A) as inconsistent with P450 chemistry, and use the strong empirical association between plant P450s and alkaloid/secondary metabolism to select B. This relies on transferable family knowledge and sequence motif recognition, not on recalling this specific entry's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent fundamentally different enzyme classes and metabolic contexts. P450 recognition cleanly eliminates C and D; the chemistry of P450s eliminates A. Only B remains as a plausible pathway for a plant P450. Minor trailing-period formatting in C and D does not affect interpretation."
  },
  "important_caveats": [
    "The P450 heme-binding motif is identifiable but requires careful inspection; a model unfamiliar with the FGxxxCxG pattern might struggle, though the overall sequence architecture still suggests a P450.",
    "The specific sub-pathway (ajmaline biosynthesis) is not asked; the broader category 'Alkaloid biosynthesis' is the correct answer level.",
    "The entry was first published in June 2025 and the supporting paper appeared in 2024; the benchmark author's source snapshot is unknown but the sequence matches exactly."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P0DXJ2",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "706fd69d57783df7add38c44c3e1cf2feb5cbcbc3afb9480407dd97165056ba4",
  "benchmark_sequence_length": 511,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 4,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-06-18",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "0a578dd2253411bfb04df1ff174b97e1095a77d1afca3ac5d5c255b61dd81670",
  "current_source_sequence_sha256": "706fd69d57783df7add38c44c3e1cf2feb5cbcbc3afb9480407dd97165056ba4",
  "current_source_sequence_length": 511,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 2,
  "selected_historical_version": {
    "accession": "P0DXJ2",
    "database": "Swiss-Prot",
    "entryVersion": 2,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "SBE2_RAUSE",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "e16d6dbcf416765b91aad19c366057399ea06101f9cb2c5bb4976186438ed810",
  "selected_historical_source_sequence_sha256": "706fd69d57783df7add38c44c3e1cf2feb5cbcbc3afb9480407dd97165056ba4",
  "selected_historical_source_sequence_length": 511,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 2,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXJ2.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXJ2.json",
  "source_sha256": "0a578dd2253411bfb04df1ff174b97e1095a77d1afca3ac5d5c255b61dd81670",
  "retrieved_utc": "2026-11-02T04:29:30.229898+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P0DXJ2\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXJ2.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXJ2.json",
  "source_sha256": "0a578dd2253411bfb04df1ff174b97e1095a77d1afca3ac5d5c255b61dd81670",
  "retrieved_utc": "2026-11-02T04:29:30.229898+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":4,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-06-18\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXJ2.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXJ2.json",
  "source_sha256": "0a578dd2253411bfb04df1ff174b97e1095a77d1afca3ac5d5c255b61dd81670",
  "retrieved_utc": "2026-11-02T04:29:30.229898+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Serpentine wood\",\"lineage\":[\"Eukaryota\",\"Viridiplantae\",\"Streptophyta\",\"Embryophyta\",\"Tracheophyta\",\"Spermatophyta\",\"Magnoliopsida\",\"eudicotyledons\",\"Gunneridae\",\"Pentapetalae\",\"asterids\",\"lamiids\",\"Gentianales\",\"Apocynaceae\",\"Rauvolfioideae\",\"Vinceae\",\"Rauvolfiinae\",\"Rauvolfia\"],\"scientificName\":\"Rauvolfia serpentina\",\"synonyms\":[\"Ophioxylon serpentinum\"],\"taxonId\":4060}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXJ2.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXJ2.json",
  "source_sha256": "0a578dd2253411bfb04df1ff174b97e1095a77d1afca3ac5d5c255b61dd81670",
  "retrieved_utc": "2026-11-02T04:29:30.229898+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"Cytochrome P450 SBE2\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000250\",\"id\":\"P0DO13\",\"source\":\"UniProtKB\"}],\"value\":\"1.14.14.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"38212296\",\"source\":\"PubMed\"}],\"value\":\"Sarpagan bridge enzyme 2\"},\"shortNames\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"38212296\",\"source\":\"PubMed\"}],\"value\":\"RsSBE2\"}]}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXJ2.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXJ2.json",
  "source_sha256": "0a578dd2253411bfb04df1ff174b97e1095a77d1afca3ac5d5c255b61dd81670",
  "retrieved_utc": "2026-11-02T04:29:30.229898+00:00",
  "json_pointer": "/comments/5",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"38212296\",\"source\":\"PubMed\"}],\"value\":\"Alkaloid biosynthesis; ajmaline biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXJ2.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXJ2.json",
  "source_sha256": "0a578dd2253411bfb04df1ff174b97e1095a77d1afca3ac5d5c255b61dd81670",
  "retrieved_utc": "2026-11-02T04:29:30.229898+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Guo J.\",\"Gao D.\",\"Lian J.\",\"Qu Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"38212296\"},{\"database\":\"DOI\",\"id\":\"10.1038/s41467-024-44797-z\"}],\"citationType\":\"journal article\",\"firstPage\":\"457\",\"id\":\"38212296\",\"journal\":\"Nat. Commun.\",\"lastPage\":\"457\",\"publicationDate\":\"2024\",\"title\":\"De novo biosynthesis of antiarrhythmic alkaloid ajmaline.\",\"volume\":\"15\"},\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [MRNA]\",\"FUNCTION\",\"PATHWAY\",\"TISSUE SPECIFICITY\",\"BIOTECHNOLOGY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXJ2?format=txt&versions=2)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXJ2?format=txt&versions=2",
  "source_sha256": "e16d6dbcf416765b91aad19c366057399ea06101f9cb2c5bb4976186438ed810",
  "retrieved_utc": "2026-11-02T04:29:34.434063+00:00",
  "source_locator": "lines 1-16",
  "excerpt": "ID   SBE2_RAUSE              Reviewed;         511 AA.\nAC   P0DXJ2;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   18-JUN-2025, sequence version 1.\nDT   28-JAN-2026, entry version 2.\nDE   RecName: Full=Sarpagan bridge enzyme 2 {ECO:0000303|PubMed:38212296};\nDE            Short=RsSBE2 {ECO:0000303|PubMed:38212296};\nDE            EC=1.14.14.- {ECO:0000250|UniProtKB:P0DO13};\nDE   AltName: Full=Cytochrome P450 SBE2 {ECO:0000305};\nGN   Name=SBE2 {ECO:0000303|PubMed:38212296};\nOS   Rauvolfia serpentina (Serpentine wood) (Ophioxylon serpentinum).\nOC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;\nOC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;\nOC   asterids; lamiids; Gentianales; Apocynaceae; Rauvolfioideae; Vinceae;\nOC   Rauvolfiinae; Rauvolfia.\nOX   NCBI_TaxID=4060;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXJ2?format=txt&versions=2)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXJ2?format=txt&versions=2",
  "source_sha256": "e16d6dbcf416765b91aad19c366057399ea06101f9cb2c5bb4976186438ed810",
  "retrieved_utc": "2026-11-02T04:29:34.434063+00:00",
  "source_locator": "lines 17-23",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, PATHWAY, TISSUE SPECIFICITY, AND\nRP   BIOTECHNOLOGY.\nRX   PubMed=38212296; DOI=10.1038/s41467-024-44797-z;\nRA   Guo J., Gao D., Lian J., Qu Y.;\nRT   \"De novo biosynthesis of antiarrhythmic alkaloid ajmaline.\";\nRL   Nat. Commun. 15:457-457(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXJ2?format=txt&versions=2)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXJ2?format=txt&versions=2",
  "source_sha256": "e16d6dbcf416765b91aad19c366057399ea06101f9cb2c5bb4976186438ed810",
  "retrieved_utc": "2026-11-02T04:29:34.434063+00:00",
  "source_locator": "lines 69-70",
  "excerpt": "CC   -!- PATHWAY: Alkaloid biosynthesis; ajmaline biosynthesis.\nCC       {ECO:0000269|PubMed:38212296}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 2,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 188. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
